User's Manual

Appendix 1: References
1. American Diabetes Association, Clinical Practice Recommendation Guidelines 2003, Diabetes
care, Vol. 26. Supplement 1. p.22
2. Stedman, TL. Stedman’s Medical Dictionary, 27th Edition, 1999, p. 2082.
3. Ellen T. Chen, James H. Nichols, Show-Hong Duh, Glen Hortin, MD: Diabetes Technology &
Therapeutics, Performance Evaluation of Blood Glucose Monitoring Devices, Oct 2003, Vol. 5,
No. 5: 749 -768
4. Siedel J, Hagele EO, Ziegenhorm J, Wahlefeld AW. Reagent for the enzymatic determination of
serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983; 29: 1075-80.
5. Expert Panel on Detection, Evaluation, and Treatment of High Cholesterol in Adults. Executive
summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert
Panel on Detection, Evaluation, and Treatment of High Cholesterol in Adults (Adult Treatment
Panel III). JAMA 2001; 285: 2486-97.
6. IDF Clinical Guidelines Task Force. Global guideline for Type 2 diabetes. Brussels; International
Diabetes Federation, 2005.
7. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a
WHO/IDF consultation. WHO, Geneva 2006 (ISBN 92 4 159493 4, ISBN 978 98 4 159793 6).
8. D’Orazio et al.: “Approved IFCC Recommendation of Reporting Results for Blood Glucose
(Abbreviated);” Clinical Chemistry 51:9 1573-1576-(2005).
9. American Diabetes Association, Position Statement, Diagnosis and Classification of Diabetes
Mellitus, Diabetes Care 35:S4-S10, 2012.
10. American Diabetes Association: Clinical Practice Recommendations (2013) Diabetes Care, Vol
36, Supplement 1, p. S1-S100
- 55 -